Literature DB >> 36101638

Prevalence, awareness, risk factors and control of hypertension in Nepal from 2000 to 2020: A systematic review and meta-analysis.

Dhan Bahadur Shrestha1, Pravash Budhathoki2, Yub Raj Sedhai3, Abinash Baniya4, Sandesh Lamichhane4, Manoj Shahi4, Bibodh Jung Karki5, Ramkaji Baniya6, Nimesh Patel7.   

Abstract

Objective: To analyse published literatures on prevalence, awareness, risk factors and control of hypertension in Nepal.
Methods: We used electronic databases to search relevant articles from January 2000 till October 2020. All relevant data from selected studies were extracted into a standardized form designed in Excel. Statistical analysis was conducted using Comprehensive Meta-Analysis Software (CMA) version 3. Proportions or Odds Ratio (OR) was used to estimate the outcome with 95% confidence interval (CI). The I-squared (I2) test was used for the assessment of heterogeneity.
Results: We identified a total of 3726 studies after comprehensive database searching. We performed qualitative and quantitative analysis of 40 studies. Pooling data showed 28.52% of patients with hypertension (CI: 26.40-30.75); 45.28% (CI: 38.89-51.83) aware of their high blood pressure; 31.66% (CI: 23.18-41.56) under treatment; 44.4% (CI: 36.17-53.04) had their blood pressure under optimum range. 27.4% (CI: 21.57-34.11) had pre-hypertensive range elevated blood pressure. 25.99% (CI: 21.81-30.65) of females and 34.25% (CI: 30.49-38.21) of male were hypertensive (p ​= ​0.007).The pooling of data showed smokers have 1.43 times (CI: 1.1429-1.7889); and alcohol users have 2.073 times (CI: 1.7154-2.5050) higher risk of having hypertension. Individuals with normal BMI have 53.15% (OR: 0.4685 CI: 0.3543-0.6195); with formal educated have 37.27% (OR: 0.6273, CI: 0.5485-0.7175); and with adequate exercise have 31.6% (OR: 0.6839, CI: 0.5203-0.8991) lower chance of having hypertension.
Conclusion: Our study shows the prevalence of hypertension in Nepal is high. However, awareness, treatment and subsequently control of high blood pressure are found to be alarmingly low. Hypertension was associated with male gender, smoking, alcohol use, high BMI, no education and inadequate exercise. It calls for more attention to address the burden of hypertension and associated risk factors in Nepal.
© 2021 The Author(s).

Entities:  

Keywords:  Alcohol use; Blood pressure; Hypertension; Nepal; Smoking

Year:  2021        PMID: 36101638      PMCID: PMC9461174          DOI: 10.1016/j.puhip.2021.100119

Source DB:  PubMed          Journal:  Public Health Pract (Oxf)        ISSN: 2666-5352


Introduction

Hypertension (HTN), which is also known as High Blood Pressure (HBP) is one of the leading preventable risk factors for premature cardiovascular diseases and mortality [1]. Persistent uncontrolled hypertension can cause complications like stroke, heart failure, atrial fibrillation, kidney failure, coronary artery diseases, peripheral vascular diseases, retinopathies and vascular dementia [[2], [3], [4]]. Factors such as unhealthy diet (especially high salt consumption), alcohol and tobacco use, increasing trends of sedentary lifestyle and ageing are attributed to the development of hypertension [5,6]. Hypertension has become one of the major challenging public health concerns globally. It was estimated that more than one billion adults were living with it in 2015, most of them belonging to low and middle income countries [[6], [7], [8]]. Globally, hypertension has reportedly been responsible for 12.8% of all total annual deaths and 3.7% of total disability-adjusted life years (DALYs) [9]. Throughout the world, the high prevalence of hypertension has significantly contributed to present cardiovascular disease pandemic and it is estimated that 29% (i.e. 1.56 billion) of the world’s adult population will be having hypertension by 2025 [6]. The prevalence, awareness and risk factors of hypertension in Nepal has not been properly studied. As much of our health system is focused on battling against communicable diseases like tuberculosis, malaria, kala-azar and other tropical diseases, there is a lack of focus towards common non-communicable diseases which account for a bulk of health problems. Thus, we aimed to evaluate the prevalence, awareness, risk factor and control of hypertension in Nepal through our meta-analysis.

Objectives

This study was aimed to determine the prevalence of hypertension in Nepal in last 20 years. Additionally, this study carried out to explore awareness, treatment status and control of blood pressure to optimum among those under treatment. Further, we assessed the risk factors related to hypertension in context to Nepal.

Methods

Protocol registration

The systematic review was registered in PROSPERO (CRD 42020212230) and was documented according to the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines [10].

Data sources and search strategy

We used electronic databases like Pubmed, Pubmed Central, Scopus and Google scholar to search relevant articles from January 2000 till October 2020 using the following MeSH terms and appropriate Boolean operators as: “hypertension” [MeSH] OR “high blood pressure” [Tiab] OR “Hypertension” AND (“prevalence” OR “risk factor”) AND “Nepal” AND PUB YEAR >1999. The detailed search strategy is documented as Supplementary Appendix 1.

Eligibility criteria

The eligibility criteria for inclusion were: (1) Cross-sectional studies, prospective and retrospective cohort studies from January 2000 till October 2020; (2) Studies reporting prevalence, awareness, control or risk factors of hypertension in adults (18 years and above) living in Nepal; (3) Published articles. We excluded (1) studies involving older adults who were attending hospital or were hospitalized for chronic diseases; (2) Studies with outcomes like self-reported hypertension; (3) Case reports, case series, narrative reviews, letter to editors, abstracts and posters. For studies with the same dataset, we considered the most comprehensive and updated one.

Study selection

We filtered the studies using COVIDENCE. Two reviewers (SL, AB) independently screened the title and abstract based on the inclusion criteria. Discrepancies were resolved by consensus obtained from the third reviewer (MS).

Data collection process and data items/data extraction

All the data were extracted independently by four reviewers (PB, AB, MS, and SL) into a standardized form designed in Excel. All reviewers were involved in verifying the accuracy and completeness of other’s work. The characteristics extracted for each selected study include: first author, year of publication, age group of participants, prevalence of hypertension and prehypertension, population under antihypertensive medication, level of awareness, those with controlled blood pressure and associated risk factors.

Summary measures

Hypertension was defined as systolic blood pressure (SBP) of 140 ​mm Hg or more, and/or diastolic blood pressure (DBP) of 90 ​mm Hg or more, or taking antihypertensive medication (JNC VII). Prehypertension was defined as SBP of 120–139 ​mm Hg and/or DBP of 80–89 ​mm Hg. Hypertension control was defined as a hypertensive patient with SBP <140 ​mm Hg and DBP <90 ​mm Hg on antihypertensive medication [11].

Data synthesis

Statistical analysis was conducted using Comprehensive Meta-Analysis Software (CMA) version 3. Proportions or Odds Ratio (OR) was used to estimate the outcome with 95% confidence interval (CI). The I-squared (I2) test was used for the assessment of heterogeneity (0%–40%- might not be important; 30% to 60%- may represent moderate heterogeneity; 50% to 90%- may represent substantial heterogeneity; 75% to 100%- considerable heterogeneity) [12]. Heterogeneity between studies was evaluated using a fixed/random-effects model. Forest plot was used to visualize the degree of variation between studies.

Risk of bias assessment based on the critical appraisal checklist

We performed the qualitative assessment of the individual study using the Joanna Briggs Institute (JBI) critical appraisal tool. This checklist consisted of 9-items that assessed the methodological quality of a study and determined the extent to which a study has addressed the possibility of bias in its design, conduct and analysis [13]. The bias assessment of 40 included studies are depicted in Table 1.
Table 1

Bias assessment.

JBI CHECKLIST(ROW)Study(COLUMN)Was the sample frame appropriate to address the target population?Were study participants sampled in an appropriate way?Was the sample size adequate?Were the study subjects and the setting described in detail?Was the data analysis conducted with sufficient coverage of the identified sample?Were valid methods used for the identification of the condition?Was the condition measured in a standard, reliable way for all participants?Was there appropriate statistical analysis?Was the response rate adequate, and if Not, was the low response rate managed appropriately?Overall Apprasial
Karki [14], 2019YESYESYESYESYESYESYESYESYESINCLUDE
Manandhar [15], 2012YESYESYESNONOYESYESYESYESINCLUDE
Kafle [16], 2018YESYESYESNONOYESYESNOYESINCLUDE
Maharjan [17], 2017YESYESYESYESYESYESYESYESYESINCLUDE
Khanal [18], 2018NONOYESYESYESYESYESYESYESINCLUDE
Chataut [19], 2011YESYESYESYESNOYESYESYESYESINCLUDE
Khanal [20], 2019YESNOYESNONOYESYESYESYESINCLUDE
Dhungana [21], 2018YESYESYESYESNOYESYESYESYESINCLUDE
Dhungana [22], 2014YESYESYESYESYESYESYESUNCLEARYESINCLUDE
Shrestha S [23], 2016YESYESYESYESYESYESYESYESYESINCLUDE
TANDSTAD [24], 2017YESYESYESYESYESYESYESYESYESINCLUDE
Shrestha D [25], 2016YESYESYESYESYESYESYESNOYESINCLUDE
Lamsal [26], 2012YESNONOYESYESYESYESNOYESINCLUDE
Mishra [27], 2019YESYESYESYESYESYESUNCLEARUNCLEARYESINCLUDE
Adhikari [28], 2020YESYESYESYESYESYESUNCLEARUNCLEARYESINCLUDE
Vaidya [29], 2012aYESYESYESYESYESYESYESYESYESINCLUDE
Ghimire [30], 2018NOYESYESYESYESYESYESYESYESINCLUDE
Anil [31], 2018NONOUNCLEARYESYESYESYESYESYESINCLUDE
Chataut [32], 2015YESYESYESYESYESYESYESUNCLEARUNCLEARINCLUDE
Dhungana [33], 2016YESYESYESYESYESYESYESYESYESINCLUDE
Shrestha [34], 2006YESYESYESYESYESYESYESYESYESINCLUDE
Vaidya [35], 2007NOYESYESYESYESYESUNCLEARYESUNCLEARINCLUDE
Koju [36], 2010YESYESYESYESYESYESUNCLEARNOUNCLEARINCLUDE
Sharma [37], 2011YESUNCLEARYESYESYESYESYESYESUNCLEARINCLUDE
Karla [38], 2011YESYESNOYESYESYESNONOUNCLEARINCLUDE
Vaidya [39], 2012bYESUNCLEARYESYESYESYESUNCLEARYESYESINCLUDE
Koju [40], 2015YESYESYESYESYESYESUNCLEARYESYESINCLUDE
Khanal [41], 2017YESYESYESYESYESYESYESYESYESINCLUDE
Sainju [42], 2018YESYESYESYESYESYESUNCLEARYESYESINCLUDE
Gyawali [43], 2019YESUNCLEARYESYESYESYESUNCLEARYESUNCLEARINCLUDE
Gupta [44], 2019YESYESYESYESYESYESYESYESYESINCLUDE
Neupane [45], 2017YESYESYESNOYESYESYESYESYESINCLUDE
Karmacharya [46], 2017NOUNCLEARNOYESYESYESYESYESUNCLEARINCLUDE
Devkota [47], 2016YESYESNOYESYESYESYESYESUNCLEARINCLUDE
Aryal [48], 2018NOYESYESYESYESYESYESYESYESINCLUDE
Vaidya [49], 2013NOYESYESYESYESYESYESYESYESINCLUDE
Pyakurel [50], 2018NOYESYESNOYESYESYESNOYESINCLUDE
Sharma [51], 2013YESNOYESYESYESYESYESYESYESINCLUDE
Vaidya [52], 2014NOYESYESYESYESYESYESYESYESINCLUDE
Mehta [53], 2011YESUNCLEARYESYESYESYESYESYESYESINCLUDE
Bias assessment.

Subgroup analysis

Subgroup analyses were conducted based on gender.

Sensitivity analysis

Sensitivity analysis for prevalence of hypertension carried out by excluding studies with participants less than 500. For other outcomes, sensitivity analysis was done excluding individual study to evaluate its effect in the overall result.

Results

We identified a total of 3726 studies after comprehensive database searching. After removal of 365 duplicates, we screened the title and abstracts of 3361 studies. We excluded 3219 studies and assessed the full-text eligibility of 142 studies. A total of 102 studies were excluded with definite reasons and we performed qualitative analysis of 40 studies. Similarly, quantitative analysis of 40 studies were done (Fig. 1).
Fig. 1

Prisma flow diagram.

Prisma flow diagram.

Qualitative analysis

The qualitative analysis of 40 included studies are depicted in Table 2. The detailed results of the qualitative synthesis are provided as Supplementary Appendix 2.
Table 2

Qualitative table.

StudyStudy typeStudy LocationStudy dateSample sizeAge groupResponse RateBP InstrumentationMeasurement frequencyTotal number of hypertension casesTotal number of pre-hypertension cases
Karki [14], 2019Community based observational cross-sectional studyRibdikot Rural Municipality and Tansen Municipality of Palpa districtMay to July 2019.37220 and aboveManual Doctor’s aneroidSphygmomanometer and stethoscope382/372 (22%)
Manandhar [15], 2012Population based cross- sectional study,11 wards of Banepa municipally, wards number 1, 3, 5, 6, 7, and 10May 15 to June 15, 2009405Above 50 populationManual Doctor’s aneroidSphygmomanometer and stethoscope2182/405 (44.9%)
Kafle [16], 2018Community-based cross-sectional surveyward numbereight of Suklagandaki municipality of Tanahu district1st November - December 30, 2017568Above 18Calibrated aneroid sphygmomanometer and stethoscope2236/568 (41.5%)
Maharjan [17], 2017Community cross sectional study4 wards (wards not specified) KirtipurMunicipalityDecember 2015 to April 2016580Age between 20 and 59 yearsManual Doctor’s aneroidSphygmomanometer and stethoscope1215/580 (37%)130/580 (22.4%)
Khanal [18], 2018Community-based cross-sectional surveyLamjung district-2014October–November 201438840–80 years of age88.9%Manual Doctor’s aneroidSphygmomanometer and stethoscope3182/345 (52.9%)
Chataut [19], 2011Cross sectional studyDhulikhel districtJanawary to march 2011527age ≥18 yearsManual mercury sphygmomanometer and stethoscope2118/527 (22.4%)253/527 (48%)
Khanal [20], 2019Descriptive cross-sectional studyDeurali Village of Nuwakot districtMay to July 2019.234age ≥18 yearsAneroid sphygmomanometer and stethoscope120/234 (8.54%)
Dhungana [21], 2018Cross sectional studySitapaila Village Development Committee, KathmanduFebruary 2014 to February 2015.34718–70yearsDoctor’s Aneroid Sphygmomanometer and stethoscope3120/347 (34.6%)
Dhungana [22], 2014Cross sectional studyTinkanya Village Development Committee, SindhuliJanuary and April 2014406age 20–50 yearsDoctor’s Aneroid Sphygmomanometer and stethoscope349/406 (12.3%)13/406 (3.2%)
Shrestha S [23], 2016Cross sectional studyChangunarayan MunicipalityApril and May 2015240aged ≥18Adult size aneroid sphygmomanometer and stethoscope349/240 (20.4%)85/240 (35.4%)
TANDSTAD [24], 2017Hospital based Cross sectional studyKirnetar health Center, Dolakha, NepalOct to Nov 2016260≥18 yearsFully automated BP monitor250/260 (19.2%)
Shrestha D [25], 2016Cross sectional studyHansposaVDC, Sunsari, NepalSep 25 to oct 25 2014351≥25 yearsAneroid sphygmomanometer3130/351 (37%)42/351 (11.97%)
Lamsal [26], 2012Cross sectional studyHigh hilly areas of ramechhap, solukhumbu and dolakha district21–25 oct 2009600≥18 yearsStandard Riva Rocci Sphygnomanometer2214/600 (35.6%)92/600 (15.33%)
Mishra [27], 2019Cross sectional studyTotal 18 sites in 7 districts covering 5 provinces (excluding province 2 and 6)May and June 20175968≥18 yearsBoth digital (OMRON) and manual sphygmomanometers31456/5968 (24.4%)
Adhikari [28], 2020Cross sectional study35 districts of NepalMay 201815561≥18 yearsBoth digital (OMRON) and manual sphygmomanometers34321/15561 (27.8%)
Vaidya [29], 2012aPopulation-based cross sectional studyDuwakot village of Bhaktapur DistrictNov 2009641≥35 yearsStandard mercury sphygmomanometer2112/641 (17.5%)
Ghimire [30], 2018Secondary analysis of STEPS survey 2013Nepal201352660–69 yearsAutomated digital blood pressure monitor292/526 (57.2%)
Anil [31], 2018Cross sectional studyKathmandu valley20145530≥18 yearsStandardized calibrated mercury column type sphygmomanometer41460/5530 (26.4%)2605/5530 (47.1%)
Chataut [32], 2015Community based cross-sectional studyRural community of Ramechap districtNR648≥18 yearsStandard mercury sphygmomanometer133/648 (20.5%)302/648 (46.6%)
Dhungana [33], 2016Community based cross-sectional studyKathmanduJan–July 2015587≥18 yearsAneroid sphygmomanometer3191/587 (32.5%)
Shrestha [34], 2006Cross sectional studySeven urban municipalities2001 to 20021012≥4085.7%Mercury sphygmomanometer2230/1012 (22.7%)
Vaidya [35], 2007Cross sectional studyDharan MunicipalityJun 2004 to Feb 20051000≥35Mercury sphygmomanometer2227/1000 (22.7%)
Koju [36], 2010Cross sectional studyDhulikhel municipality200779618-88 (48.41 ​± ​17.38)Mercury sphygmomanometer2230/796 (28.9%)42/230 (18.3)
Sharma [37], 2011Cross sectional studyEastern region20071442220-100 (41.4 ​± ​15.1)Mercury sphygmomanometer14894/14422 (33.9%)
Karla [38], 2011Cross sectional studyDharan MunicipalityNR11935-86 (54.1 ​± ​10.5)NRNR42/119 (35.3%)
Vaidya [39], 2012bCross sectional studyBhadrabas village area of Kathmandu valley20061218≥21 (40.54 ​± ​16)84%Mercury sphygmomanometerNR412/1218 (33.8%)
Koju [40], 2015Cross sectional studyNationwideMay-13210018-65 (34.4 ​± ​12.8)99.6%Digital2317/2100 (15.1%)915/2100 (43.6%)
Khanal [41], 2017Cross sectional studyBirendranagar Municipality of Surkhet DistrictJan to Dec 20161159≥30 (47 ​± ​12.6)Aneroid sphygmomanometer2451/1159 (38.9%)
Sainju [42], 2018Cross sectional studySindupalchowk District20161243≥18 (48.73 ​± ​16.25)Mercury sphygmomanometer1375/1243 (30.17%)137/1243 (11.02%)
Gyawali [43], 2019Cross sectional studyPokhara Metropolitan City2016231025–64Digital2797/2310 (34.5%)
Gupta [44], 2019Secondary analysis of NDHS SurveyEntire NepalJune 2016 to January 201713393Above or equal to 18A & D Medical BP Monitor32827/13393(21.1%, 95% CI ​= ​19.9% - 22.4%)
Neupane [45], 2017Cross- sectional surveyLekhnath Municipality, Western Nepal2013281525–65 year old80%Digital Sphygmomanometer328% (95% CI ​= ​26–30%)
Karmacharya [46], 2017Cross-sectional studyDhulikhelNovember 2013–February 20151073Above 18Standard Digital Blood Pressure Machine3298/1073 (27.78%)
Devkota [47], 2016Community cross sectional studyMunicipalities of Kathmandu DistrictJanuary–July 201558718–70 yearsAneroidSphygmomanometer and stethoscope3191/587 (32.5%)
Aryal [48], 2018Cross-sectional survey of high altitudeMore than 2800 ​m from sea level in Mustang and HumlaJune 2014–August 2014March 2015–May 2015521More than 30 years90%Automatic blood pressure measuring device3181/521 (34.74%)159/521 (30.52%)
Vaidya [49], 2013Community based cross-sectional studyBhaktapur district of Kathmandu ValleySeptember to November 201177725–59 years94.07%Automated measurement3168/777 (21%)
Pyakurel [50], 2018Cross-sectional studyEastern Nepal Sunsari and MorangJuly 2012 to July 201349420–59 yearsStandard technique2166/494 (33.60%)205/494 (41.5%)
Sharma [51], 2013Community based surveyDharan2003–20053218More than 20 years1243/3218 (38.6%)
Vaidya [52], 2014Population based cross-sectional analytical studyDharan Municipality2004–20051000Above 35 years oldStandard mercury sphygmomanometer2227/1000 (22.7%)
Mehta [53], 2011Cross-sectional studySunsari District, Eastern NepalSeptember 2005–July 20061270Above 30 years92.7% and 95%In rural and urban respectivelyStandard adult mercury sphygmomanometer1615/1935 (31%)752/1935 (38.86%)
Qualitative table.

Quantitative analysis

Total 40 studies were included in quantitative synthesis.

Prevalence of hypertension

Using random effect model pooling data from 40 studies showed 28.52% patient with hypertension (Proportion: 0.2852; CI: 0.2640–0.3075; I2: 97.73) (Fig. 2). Sensitivity analysis done excluding individual studies and studies with sample size of less than 500; showed no significant changes (Supplementary Appendix 3; Fig. 1, Fig. 2). Further analysis for prevalence of hypertension based on the timeframe and re-running analysis using random effect showed 26.92% hypertension between 2011 and 2015 (Proportion, 0.2692; CI, 0.2277–0.3152). Similarly, prevalence of hypertension was 31% for 2016–2020 (Proportion, 0.3100; CI, 0.2797–0.3421) (Supplementary Appendix 3; Figs. 3 and 4).
Fig. 2

Prevalence of hypertension.

Prevalence of hypertension.

Awareness of hypertensive status

Total 12 studies showed hypertensive awareness status, pooling of data among those studies using random-effect model showed 45.28% of hypertensive patients only aware of the fact that they have high blood pressure (Proportion: 0.4528; CI: 0.3889–0.5183; I2: 95.27%) (Fig. 3). Sensitivity analysis excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 5).
Fig. 3

Meta-analysis pooling data on awareness status of hypertensive patients.

Meta-analysis pooling data on awareness status of hypertensive patients. Meta-analysis pooling data on treatment status of hypertensive patients.

Hypertensive individuals under treatment

Seventeen studies reported treatment status among hypertensive patients. Among hypertensive individuals 31.66% were under some form of treatment for their hypertension (Proportion: 0.3166; CI: 0.2318–0.4156; I2: 99.09%) (Fig. 4). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 6).
Fig. 4

Meta-analysis pooling data on treatment status of hypertensive patients.

BP under control among patient under treatment

Twelve studies reported blood pressure status among hypertensive patients receiving their treatment. Among hypertensive individuals under some form of treatment, 44.4% have their blood pressure under optimum range (Proportion: 0.4444; CI: 0.3617–0.5304; I2: 94.8) (Fig. 5). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 7).
Fig. 5

Meta-analysis pooling data on blood pressure under control among hypertensive patients receiving their treatment.

Meta-analysis pooling data on blood pressure under control among hypertensive patients receiving their treatment.

Prevalence of pre-hypertension

Fourteen studies reported prevalence of pre-hypertension in their study population. Pooling data from all 14 studies showed 27.4% have pre-hypertensive range elevation in blood pressure (Proportion: 0.2740; CI: 0.2157–0.3411; I2: 98.65) (Fig. 6). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 8).
Fig. 6

Meta-analysis pooling data prevalence of pre-hypertension.

Meta-analysis pooling data prevalence of pre-hypertension.

Prevalence of hypertension based on gender

Twenty-six studies segregated the prevalence of hypertension among females and 27 studies among male. Pooling of data showed 25.99% of females were hypertensive (Proportion: 0.2599; CI: 0.2181–0.3065; I2: 98.59) while 34.25% of male were hypertensive (Proportion: 0.3425; CI: 0.3049–0.3821; I2: 97.21%) and difference was significant (p ​= ​0.007) (Supplementary Appendix 3; Fig. 9).

Smoking and hypertension

Thirteen studies reported smoking status among hypertensive individuals. The pooling of data using random-effect model showed smokers have 1.43 times higher odds of having hypertension comparing with non-smokers (OR: 1.4299, CI: 1.1429–1.7889; I2: 75.82) (Fig. 7). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 10).
Fig. 7

Meta-analysis pooling smoking status and hypertension.

Fig. 10

Meta-analysis pooling relation of education and hypertension.

Meta-analysis pooling smoking status and hypertension.

Alcohol use and hypertension

Twelve studies reported alcohol use habits among hypertensive individuals. The pooling of data using random-effect model showed alcohol users have 2.073 times higher odds of having hypertension comparing with alcohol non-users (OR: 2.0729; CI: 1.7154–2.5050; I2: 63.56) (Fig. 8). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 11).
Fig. 8

Meta-analysis pooling alcohol use status and hypertension.

Fig. 11

Meta-analysis pooling relation of exercise and hypertension.

Meta-analysis pooling alcohol use status and hypertension.

BMI and hypertension

Twelve studies reported BMI among hypertensive individuals. The pooling of data using random-effect model showed having normal BMI has 53.15% lower odds of having hypertension (OR: 0.4685; CI: 0.3543–0.6195; I2 ​= ​91.57) (Fig. 9). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 12).
Fig. 9

Meta-analysis pooling relation of BMI and hypertension.

Meta-analysis pooling relation of BMI and hypertension.

Education and hypertension

Twelve studies reported education status among hypertensive individuals. The pooling of data using random-effect model showed formal education has 37.27% lower odds of having hypertension (OR: 0.6273; CI: 0.5485–0.7175; I2 ​= ​67.25) (Fig. 10). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 13). Meta-analysis pooling relation of education and hypertension.

Exercise and hypertension

Eight studies reported exercise among hypertensive individuals. The pooling of data using random-effect model showed adequate exercise has 31.61% lower odds of having hypertension (OR: 0.6839; CI: 0.5203–0.8991; I2 ​= ​83.82) (Fig. 11). Sensitivity analysis performed excluding individual studies showed no significant differences (Supplementary Appendix 3; Fig. 14). Meta-analysis pooling relation of exercise and hypertension.

Diet, stress, salt intake, residential set-up and hypertension

The pooling of data using random-effect model showed no differences among diet type and hypertension (OR: 0.7568; CI: 0.4022–1.4238; I2 ​= ​71.16) (Supplementary Appendix 3; Fig. 15 and 16). The pooling of data using random-effect model did not show a statistically significant association of stress with and hypertension (OR: 2.6887; CI: 0.6840–10.5688; I2 ​= ​93.21) (Supplementary Appendix 3; Fig. 17 and 18). The pooling of data using random-effect model did not show a statistically significant association of salt intake and hypertension (OR: 1.200; CI: 0.7581–1.8997; I2 ​= ​61.19) (Supplementary Appendix 3; Fig. 19). The pooling of data using random-effect model did not show a statistically significant association of residential setup and hypertension (OR: 0.8891; CI: 0.7235–1.0927; I2 ​= ​62.78) (Supplementary Appendix 3; Fig. 20). Pooling of data on diet, stress, salt intake and residential set-up did not show significant relation with hypertension in this analysis. This may be because of less number of studies reporting these outcomes.

Discussion

We analyzed 40 studies done in different parts of Nepal after thorough database searching. We found out that hypertension and pre-hypertension are major health problems in Nepal with a prevalence of 28.52% and 27.5% respectively. The results are alarming because 56.02% have a different spectrum of hypertension disorders. The prevalence of pre-hypertension in our study was lower than that reported by Huang et al. (35.4%) which analyzed studies from 2000 to 2018, however, the prevalence of hypertension appears to be similar [54]. The prevalence of hypertension and pre-hypertension in Nepal was similar to the overall prevalence among SAARC countries as reported by Neupane et al. [55] Nepal has the third-highest prevalence of hypertension among the SAARC countries behind Maldives (31.5%) and India (31.4%) [55]. However, the prevalence of hypertension was lower than the global prevalence of hypertension which stands at 40.8% [56]. Only 45.23% of patients with hypertension were aware that they have hypertension. This is lower than the overall awareness in South Asia and Africa where 64.9% and 50.6% were aware that they had hypertension on the diagnosis [56]. Only 31.66% were under some form of antihypertensive following their diagnosis which was lower than 57.8% in South Asia and 46.6% in Africa [56]. This may be attributed to lack of affordability, poor patient counseling regarding the necessity of adhering to treatment, inaccessible health services and increased costs during follow up with physicians. Although a national Multi-Sectoral Action Plan (2014–2020) for prevention of hypertension has been developed, there is still a lack of necessary awareness about this condition and poor compliance with the intake of medication [57]. WHO has emphasized on a core set of interventions addressed at primary care level that should be made accessible to all people based on their need and ability to pay as per the WHO Package of Essential Non-Communicable Disease that was implemented in Nepal in 2016 [58]. However, most of the primary care centers at Nepal are understaffed and have inadequate resources to tackle non-communicable diseases. Further, only 44.4% of patients had optimum control of blood pressure. The optimum control of blood pressure was better than in South Asia and Africa where blood pressure was controlled in 24% and 10.6% of the population. Hypertension was found more in males compared to females in Nepal which was similar to the study done in 2018. Similarly, multiple studies have found hypertension to be more common in males compared to females [55,56,59]. We also found an increased risk of hypertension with smoking, drinking alcohol and obesity while higher education and exercise were associated with decreased risk of hypertension. A study in China found an increased risk for hypertension with habitual alcohol use, less physical activity and exercise which is concordant with our finding [59]. Our finding of an association of increased BMI with hypertension was similar to the study done by Neupane et al. which showed a significant association of obesity with hypertension throughout different SAARC countries [55]. We found no association of hypertension with stress, vegetarian diet and excess salt intake. This can be explained by the lack of relevant data about these variables in most of our included studies. Our study has several strengths. Our meta-analysis is the first meta-analysis to provide comprehensive details about the prevalence, awareness and risk factors of hypertension in Nepal. Although a previous study done in 2018 reported the prevalence of hypertension and pre-hypertension in Nepal, it included 23 studies and also did not give an idea about the awareness levels and risk factors of hypertension in Nepal [54]. On the other hand, our meta-analysis includes 40 studies. Also, the findings of our study are significant because it highlights the lack of awareness in more than half of people with hypertension about their condition and that more than two-thirds of hypertensive patients do not take any medications. The following condition is worse than some of the least developed parts in the world including the countries in Africa. There is a real need on the side of the government to prioritize the diagnosis, management and prevention of hypertension throughout the country by focusing on modifiable risk factors. Greater awareness needs to be spread regarding the risks of smoking, regular use of alcohol, less physical activity and obesity. In line with the WHO’s package for non-communicable diseases, the primary care centers should be improved, and promotion of health through activities like tobacco cessation, regular physical activity for 30 ​min, decreased salt intake and a diet rich in vegetables and fruits should be done. Patients should be educated by health professionals about the necessity to be compliant with cost-effective medications and about the different cardiovascular risks of untreated hypertension. The alarming findings of our study and the necessary attention it will generate among the concerned authorities add to the significance of our study.

Limitations

Our study has several limitations too. Firstly, we included a wide variety of studies with different sample sizes ranging from low to high and people of different socio-demographic features and from various locations. These factors have contributed to significant heterogeneity among the included studies. We also add that studies did not use the current definition of American Heart Association classification of hypertension being all our study were based on prior definition, if had been used would have further increased the prevalence of Hypertension. Also, we could not reach firm association of hypertension with several key factors like added salt, stress and DASH diet because of lack of adequate data. Some of the included studies included males only which might have contributed to the increased association of male gender with hypertension. Nepalese community do have some belief towards traditional cultural belief so try not to begin medication in early may have affected the treatment and its compliance.

Conclusion

The prevalence of hypertension and pre-hypertension were found to be 28.52% and 27.5% respectively encompassing more than half of the population. Despite widespread prevalence, the awareness of patients regarding their condition and compliance with treatment were found to be alarmingly low. The optimum control of blood pressure was 44.4% following treatment. Hypertension was associated with male gender, smoking, drinking alcohol and increased BMI. Increased attention should be given by the government and concerned agencies to implement core strategies proposed by WHO to decrease the modifiable risk factors for hypertension.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

The datasets analyzed during the current study is available in supplementary appendix 2.

Funding

This article did not receive any specific grant from funding agencies in the public, commercial, or any other sectors.

Authors’ contributions

DBS, PB, and YRS contributed to the concept and design, analysis, and interpretation of data. DBS, PB, AB, SL, MS, BJK, RKB and NP contributed to the literature search, data extraction, review and initial manuscript drafting. All authors were involved in drafting and revising the manuscript and approved the final version.

Declaration of competing interest

The authors declare that they have no competing interests.
  46 in total

1.  The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal.

Authors:  U K Shrestha; D L Singh; M D Bhattarai
Journal:  Diabet Med       Date:  2006-10       Impact factor: 4.359

2.  Prevalence and associated risk factors of hypertension among people aged 50 years and more in Banepa Municipality, Nepal.

Authors:  K Manandhar; R Koju; N P Sinha; S Humagain
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2012 Jul-Sep

3.  Is ethnicity an important determinant of high blood pressure in Nepalese population? A community-based cross sectional study in Duwakot, Nepal.

Authors:  A Vaidya
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2012 Jan-Mar

Review 4.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

5.  Prevalence and Awareness of Hypertension among Adults and its Related Risk Factors.

Authors:  Basanta Maharjan
Journal:  J Nepal Health Res Counc       Date:  2018-01-01

6.  Hyperglycemia, glucose intolerance, hypertension and socioeconomic position in eastern Nepal.

Authors:  K D Mehta; P Karki; M Lamsal; I S Paudel; S Majhi; B K L Das; S Sharma; N Jha; N Baral
Journal:  Southeast Asian J Trop Med Public Health       Date:  2011-01       Impact factor: 0.267

7.  Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.

Authors:  Katherine T Mills; Joshua D Bundy; Tanika N Kelly; Jennifer E Reed; Patricia M Kearney; Kristi Reynolds; Jing Chen; Jiang He
Journal:  Circulation       Date:  2016-08-09       Impact factor: 29.690

8.  Prevalence of cardiovascular health risk behaviors in a remote rural community of Sindhuli district, Nepal.

Authors:  Raja Ram Dhungana; Surya Devkota; Mahesh Kumar Khanal; Yadav Gurung; Rajendra Kumar Giri; Ram Krishna Parajuli; Anup Adhikari; Suira Joshi; Barsha Hada; Arun Shayami
Journal:  BMC Cardiovasc Disord       Date:  2014-07-28       Impact factor: 2.298

9.  Prevalence and clustering of cardiovascular disease risk factors in rural Nepalese population aged 40-80 years.

Authors:  Mahesh Kumar Khanal; M S A Mansur Ahmed; Mohammad Moniruzzaman; Palash Chandra Banik; Raja Ram Dhungana; Pratiksha Bhandari; Surya Devkota; Arun Shayami
Journal:  BMC Public Health       Date:  2018-05-31       Impact factor: 3.295

View more
  1 in total

1.  Medication non-compliance: A challenge in treating hypertension in Nepal.

Authors:  Saral Lamichhane; Amrit Pokhrel; Nava Raj Sharma
Journal:  Ann Med Surg (Lond)       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.